Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Comparison of severe healthcare-associated pneumonia with severe community-acquired pneumonia.

Jeong BH, Jeon EJ, Yoo H, Koh WJ, Suh GY, Chung MP, Kwon OJ, Jeon K.

Lung. 2014 Apr;192(2):313-20. doi: 10.1007/s00408-013-9541-x. Epub 2013 Dec 1.

PMID:
24292398
2.

The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea.

Jeon EJ, Cho SG, Shin JW, Kim JY, Park IW, Choi BW, Choi JC.

Yonsei Med J. 2011 Mar;52(2):282-7. doi: 10.3349/ymj.2011.52.2.282.

3.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
4.

Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.

Falcone M, Venditti M, Shindo Y, Kollef MH.

Int J Infect Dis. 2011 Aug;15(8):e545-50. doi: 10.1016/j.ijid.2011.04.005. Epub 2011 May 26. Review.

5.

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS.

Clin Infect Dis. 2013 Nov;57(10):1373-83. doi: 10.1093/cid/cit571. Epub 2013 Sep 2.

6.

One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System.

Hsu JL, Siroka AM, Smith MW, Holodniy M, Meduri GU.

Int J Infect Dis. 2011 Jun;15(6):e382-7. doi: 10.1016/j.ijid.2011.02.002. Epub 2011 Mar 9.

7.

Risk factors for acquiring potentially drug-resistant pathogens in immunocompetent patients with pneumonia developed out of hospital.

Jeong BH, Koh WJ, Yoo H, Park HY, Suh GY, Chung MP, Kwon OJ, Jeon K.

Respiration. 2014;88(3):190-8. doi: 10.1159/000362673. Epub 2014 Jul 2.

PMID:
24994099
8.

Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.

Simonetti A, Viasus D, Garcia-Vidal C, Adamuz J, Roset A, Manresa F, Dorca J, Gudiol F, Carratalà J.

Clin Microbiol Infect. 2012 Nov;18(11):1149-55. doi: 10.1111/j.1469-0691.2011.03709.x. Epub 2011 Nov 24.

9.
10.

Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality.

Oster G, Berger A, Edelsberg J, Weber DJ.

J Med Econ. 2013;16(6):809-19. doi: 10.3111/13696998.2013.794805. Epub 2013 May 15.

PMID:
23574431
11.

[The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia].

Taşbakan MS, Bacakoğlu F, Başoğlu OK, Gürgün A, Başarik B, Citim Tuncel S, Sayiner A.

Tuberk Toraks. 2011;59(4):348-54. Turkish.

12.

Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients.

Park SC, Kim EY, Kang YA, Park MS, Kim YS, Kim SK, Chang J, Jung JY.

Int J Tuberc Lung Dis. 2013 May;17(5):704-9. doi: 10.5588/ijtld.12.0723.

PMID:
23575340
13.

Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.

Grenier C, Pépin J, Nault V, Howson J, Fournier X, Poirier MS, Cabana J, Craig C, Beaudoin M, Valiquette L.

J Antimicrob Chemother. 2011 Jul;66(7):1617-24. doi: 10.1093/jac/dkr176. Epub 2011 May 17.

14.

Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital.

Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, Imaizumi K, Sato T, Hasegawa Y.

Chest. 2009 Mar;135(3):633-40. doi: 10.1378/chest.08-1357. Epub 2008 Nov 18.

PMID:
19017892
15.

Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital.

Jung JY, Park MS, Kim YS, Park BH, Kim SK, Chang J, Kang YA.

BMC Infect Dis. 2011 Mar 11;11:61. doi: 10.1186/1471-2334-11-61.

16.

Guideline-concordant therapy and outcomes in healthcare-associated pneumonia.

Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM.

Eur Respir J. 2011 Oct;38(4):878-87. doi: 10.1183/09031936.00141110. Epub 2011 Mar 24.

17.

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience.

Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH.

Antimicrob Agents Chemother. 2007 Oct;51(10):3568-73. Epub 2007 Aug 6.

18.

Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia.

Rello J, Luján M, Gallego M, Vallés J, Belmonte Y, Fontanals D, Diaz E, Lisboa T; PROCORNEU Study Group.

Chest. 2010 May;137(5):1138-44. doi: 10.1378/chest.09-2175. Epub 2009 Dec 1.

PMID:
19952058
19.
20.

Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia.

Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR.

Respir Med. 2012 Nov;106(11):1606-12. doi: 10.1016/j.rmed.2012.08.003. Epub 2012 Aug 21.

Items per page

Supplemental Content

Write to the Help Desk